Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 2/2019

25.04.2019

Functions of stem cells of thyroid glands in health and disease

verfasst von: Ebtesam A. Al-Suhaimi, Khulood Al-Khater

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Thyroid gland has been implicated in the regulation of many functions using endocrine, paracrine and autocrine signals. Functional thyroid follicular cells derived from stem cells attracted a great interest from researchers as a strategy for thyroid’s regenerative therapy. Thyroid has a very low rate of turnover; however, studies showed that the regenerative ability is enhanced following diseases or thyroidectomy, which promotes the role of stem cell. The objective of this review is to summarize the morphological characterization and the expression of stem cell genes/markers in the thyroid. Also, to highlight the mechanisms of tumor formation in thyroid via its stem cells. The most important thyroid stem cell’s markers are: stem cell antigen 1 (SCA-1), octamer-binding transcription 4 (OCT-4), p63, CD34+ CD45-, paired box gene 8 (PAX-8), thyroid transcription factor 1 (TTF-1), thyroid transcription factor 2 (TTF-2), hematopoietically expressed homeobox protein HHEX, the transcription factor GATA-4, hepatocyte nuclear factor 4-α (HNF-4-α) and homeobox transcription factor Nanog (hNanog). This review highlights the functional characterization describing the mechanisms of stem cell’s differentiation into functional thyroid follicle and proposing mechanisms involving in cancer formation through one of these cell types: fetal cell, thyroblasts, prothyrocytes, certain genetic mutation in the mature thyroid cells or presence of a special type of cells (cancer stem cell) which are responsible for different types of cancer formation. Understanding the mechanisms of thyroid’s stem cell in cancer formation and the expression of the biomarkers in normal and abnormal thyroid status are promising physiological tools in promoting thyroid regeneration and in provision management for thyroid cancer.
Literatur
1.
Zurück zum Zitat Ozaki T, Matsubara T, Seo D, Okamoto M, Nagashima K, Sasaki Y, et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology. 2012;153(5):2514–25.PubMedPubMedCentralCrossRef Ozaki T, Matsubara T, Seo D, Okamoto M, Nagashima K, Sasaki Y, et al. Thyroid regeneration: characterization of clear cells after partial thyroidectomy. Endocrinology. 2012;153(5):2514–25.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Sadler, T. W. and Langman, J. M. E. (2010) Langman's medical embryology. 11th ed., international ed. / T.W. Sadler ; original illustrations by Jill Leland ; computer illustrations by Susan L. Sadler-Redmond ; scanning electron micrographs by Kathy Tosney ; ultrasound images by Nancy Cheschier and Hytham Imseis. edn. Philadelphia: Wouters Kluwer/Lippincott Williams & Wilkins. Sadler, T. W. and Langman, J. M. E. (2010) Langman's medical embryology. 11th ed., international ed. / T.W. Sadler ; original illustrations by Jill Leland ; computer illustrations by Susan L. Sadler-Redmond ; scanning electron micrographs by Kathy Tosney ; ultrasound images by Nancy Cheschier and Hytham Imseis. edn. Philadelphia: Wouters Kluwer/Lippincott Williams & Wilkins.
3.
Zurück zum Zitat Johansson E, Andersson L, Örnros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142(20):3519–28.PubMedPubMedCentralCrossRef Johansson E, Andersson L, Örnros J, Carlsson T, Ingeson-Carlsson C, Liang S, et al. Revising the embryonic origin of thyroid C cells in mice and humans. Development. 2015;142(20):3519–28.PubMedPubMedCentralCrossRef
4.
5.
Zurück zum Zitat Salvatore D. Deiodinases and stem cells: an intimate relationship. J Endocrinol Investig. 2018;41(1):59–66.CrossRef Salvatore D. Deiodinases and stem cells: an intimate relationship. J Endocrinol Investig. 2018;41(1):59–66.CrossRef
6.
Zurück zum Zitat Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Sobhani A. Multipotent stem cell and reproduction. J Stem Cells. 2016;11(4):219–29.PubMed Khanlarkhani N, Baazm M, Mohammadzadeh F, Najafi A, Mehdinejadiani S, Sobhani A. Multipotent stem cell and reproduction. J Stem Cells. 2016;11(4):219–29.PubMed
7.
8.
Zurück zum Zitat Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992;72(3):667–97.PubMedCrossRef Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992;72(3):667–97.PubMedCrossRef
9.
Zurück zum Zitat Johansen R, Gardner RE, Galante M, Marchi FF, Ledwich TW, SOLEY MH, et al. An experimental study of thyroid regeneration following subtotal thyroidectomy. Surg Gynecol Obstet. 1951;93(3):303–9.PubMed Johansen R, Gardner RE, Galante M, Marchi FF, Ledwich TW, SOLEY MH, et al. An experimental study of thyroid regeneration following subtotal thyroidectomy. Surg Gynecol Obstet. 1951;93(3):303–9.PubMed
10.
Zurück zum Zitat Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology. 2007;148(9):4251–8.PubMedPubMedCentralCrossRef Hoshi N, Kusakabe T, Taylor BJ, Kimura S. Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology. 2007;148(9):4251–8.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Chen CY, Kimura H, Landek-Salgado MA, Hagedorn J, Kimura M, Suzuki K, et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology. 2009;150(1):492–9.PubMedCrossRef Chen CY, Kimura H, Landek-Salgado MA, Hagedorn J, Kimura M, Suzuki K, et al. Regenerative potentials of the murine thyroid in experimental autoimmune thyroiditis: role of CD24. Endocrinology. 2009;150(1):492–9.PubMedCrossRef
12.
Zurück zum Zitat Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, et al. The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res. 2011;345(3):313–28.PubMedCrossRef Lehner B, Sandner B, Marschallinger J, Lehner C, Furtner T, Couillard-Despres S, et al. The dark side of BrdU in neural stem cell biology: detrimental effects on cell cycle, differentiation and survival. Cell Tissue Res. 2011;345(3):313–28.PubMedCrossRef
13.
Zurück zum Zitat Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S. 'Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration. PLoS One. 2013;8(11):e80801.PubMedPubMedCentralCrossRef Okamoto M, Hayase S, Miyakoshi M, Murata T, Kimura S. 'Stem cell antigen 1-positive mesenchymal cells are the origin of follicular cells during thyroid regeneration. PLoS One. 2013;8(11):e80801.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Kimura S. Thyroid regeneration: how stem cells play a role? Front Endocrinol (Lausanne). 2014;5:55. Kimura S. Thyroid regeneration: how stem cells play a role? Front Endocrinol (Lausanne). 2014;5:55.
15.
Zurück zum Zitat Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol. 2003;16(1):43–8.PubMedCrossRef Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simões M. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol. 2003;16(1):43–8.PubMedCrossRef
16.
Zurück zum Zitat Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 2006;16(6):537–44.PubMedCrossRef Thomas T, Nowka K, Lan L, Derwahl M. Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 2006;16(6):537–44.PubMedCrossRef
17.
Zurück zum Zitat Lan L, Cui D, Nowka K, Derwahl M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab. 2007;92(9):3681–8.PubMedCrossRef Lan L, Cui D, Nowka K, Derwahl M. Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab. 2007;92(9):3681–8.PubMedCrossRef
18.
Zurück zum Zitat Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol. 2008;198(3):471–87.PubMedCrossRef Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M. Identification of an adult stem/progenitor cell-like population in the human thyroid. J Endocrinol. 2008;198(3):471–87.PubMedCrossRef
19.
Zurück zum Zitat Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics. 1992;12(4):788–94.PubMedCrossRef Satterthwaite AB, Burn TC, Le Beau MM, Tenen DG. Structure of the gene encoding CD34, a human hematopoietic stem cell antigen. Genomics. 1992;12(4):788–94.PubMedCrossRef
20.
Zurück zum Zitat Korostylev A, Mahaddalkar PU, Keminer O, Hadian K, Schorpp K, Gribbon P, et al. A high-content small molecule screen identifies novel inducers of definitive endoderm. Mol Metab. 2017;6(7):640–50.PubMedPubMedCentralCrossRef Korostylev A, Mahaddalkar PU, Keminer O, Hadian K, Schorpp K, Gribbon P, et al. A high-content small molecule screen identifies novel inducers of definitive endoderm. Mol Metab. 2017;6(7):640–50.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Lin RY, Kubo A, Keller GM, Davies TF. Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology. 2003;144(6):2644–9.PubMedCrossRef Lin RY, Kubo A, Keller GM, Davies TF. Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology. 2003;144(6):2644–9.PubMedCrossRef
22.
Zurück zum Zitat Arufe MC, Lu M, Kubo A, Keller G, Davies TF, Lin RY. Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology. 2006;147(6):3007–15.PubMedPubMedCentralCrossRef Arufe MC, Lu M, Kubo A, Keller G, Davies TF, Lin RY. Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology. 2006;147(6):3007–15.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun. 2009;381(2):264–70.PubMedPubMedCentralCrossRef Arufe MC, Lu M, Lin RY. Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun. 2009;381(2):264–70.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Ma R, Latif R, Davies TF. Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin a. Endocrinology. 2009;150(4):1970–5.PubMedCrossRef Ma R, Latif R, Davies TF. Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin a. Endocrinology. 2009;150(4):1970–5.PubMedCrossRef
25.
Zurück zum Zitat Jiang N, Hu Y, Liu X, Wu Y, Zhang H, Chen G, et al. Differentiation of E14 mouse embryonic stem cells into thyrocytes in vitro. Thyroid. 2010;20(1):77–84.PubMedCrossRef Jiang N, Hu Y, Liu X, Wu Y, Zhang H, Chen G, et al. Differentiation of E14 mouse embryonic stem cells into thyrocytes in vitro. Thyroid. 2010;20(1):77–84.PubMedCrossRef
26.
Zurück zum Zitat Ma R, Latif R, Davies TF. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells. Thyroid. 2013;23(4):385–91.PubMedPubMedCentralCrossRef Ma R, Latif R, Davies TF. Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells. Thyroid. 2013;23(4):385–91.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Arauchi A, Matsuura K, Shimizu T, Okano T. Functional thyroid follicular cells differentiation from human-induced pluripotent stem cells in suspension culture. Front Endocrinol (Lausanne). 2017;8:103.CrossRef Arauchi A, Matsuura K, Shimizu T, Okano T. Functional thyroid follicular cells differentiation from human-induced pluripotent stem cells in suspension culture. Front Endocrinol (Lausanne). 2017;8:103.CrossRef
28.
Zurück zum Zitat Antonica F, Kasprzyk DF, Opitz R, Iacovino M, Liao XH, Dumitrescu AM, et al. Generation of functional thyroid from embryonic stem cells. Nature. 2012;491(7422):66–71.PubMedPubMedCentralCrossRef Antonica F, Kasprzyk DF, Opitz R, Iacovino M, Liao XH, Dumitrescu AM, et al. Generation of functional thyroid from embryonic stem cells. Nature. 2012;491(7422):66–71.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Davies TF, Latif R, Minsky NC, Ma R. Clinical review: the emerging cell biology of thyroid stem cells. J Clin Endocrinol Metab. 2011;96(9):2692–702.PubMedPubMedCentralCrossRef Davies TF, Latif R, Minsky NC, Ma R. Clinical review: the emerging cell biology of thyroid stem cells. J Clin Endocrinol Metab. 2011;96(9):2692–702.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Onyshchenko MI, Panyutin IG, Panyutin IV, Neumann RD. Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells. Stem Cells Int. 2012;2012:634914.PubMedPubMedCentralCrossRef Onyshchenko MI, Panyutin IG, Panyutin IV, Neumann RD. Stimulation of cultured h9 human embryonic stem cells with thyroid stimulating hormone does not lead to formation of thyroid-like cells. Stem Cells Int. 2012;2012:634914.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Hick AC, Delmarcelle AS, Bouquet M, Klotz S, Copetti T, Forez C, et al. Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation. Dev Biol. 2013;381(1):227–40.PubMedCrossRef Hick AC, Delmarcelle AS, Bouquet M, Klotz S, Copetti T, Forez C, et al. Reciprocal epithelial:endothelial paracrine interactions during thyroid development govern follicular organization and C-cells differentiation. Dev Biol. 2013;381(1):227–40.PubMedCrossRef
32.
Zurück zum Zitat Murata T, Iwadate M, Takizawa Y, Miyakoshi M, Hayase S, Yang W, et al. An adult mouse thyroid side population cell line that exhibits enriched epithelial-mesenchymal transition. Thyroid. 2017;27(3):460–74.PubMedPubMedCentralCrossRef Murata T, Iwadate M, Takizawa Y, Miyakoshi M, Hayase S, Yang W, et al. An adult mouse thyroid side population cell line that exhibits enriched epithelial-mesenchymal transition. Thyroid. 2017;27(3):460–74.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58–64.PubMedCrossRef Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6(2):58–64.PubMedCrossRef
34.
Zurück zum Zitat Alghamdi IG, Hussain II, Alghamdi MS, Dohal AA, Almalki SS, El-Sheemy MA. The incidence rate of thyroid cancer among women in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer registry 2001-2008. J Immigr Minor Health. 2015;17(3):638–43.PubMedCrossRef Alghamdi IG, Hussain II, Alghamdi MS, Dohal AA, Almalki SS, El-Sheemy MA. The incidence rate of thyroid cancer among women in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer registry 2001-2008. J Immigr Minor Health. 2015;17(3):638–43.PubMedCrossRef
35.
Zurück zum Zitat Zane M, Scavo E, Catalano V, Bonanno M, Todaro M, De Maria R, et al. Normal vs cancer thyroid stem cells: the road to transformation. Oncogene. 2016;35(7):805–15.PubMedCrossRef Zane M, Scavo E, Catalano V, Bonanno M, Todaro M, De Maria R, et al. Normal vs cancer thyroid stem cells: the road to transformation. Oncogene. 2016;35(7):805–15.PubMedCrossRef
36.
Zurück zum Zitat Gao YJ, Li B, Wu XY, Cui J, Han JK. Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review). Oncol Rep. 2014;31(3):1035–42.PubMedPubMedCentralCrossRef Gao YJ, Li B, Wu XY, Cui J, Han JK. Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review). Oncol Rep. 2014;31(3):1035–42.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Cicatiello AG, Ambrosio R, Dentice M. Thyroid hormone promotes differentiation of colon cancer stem cells. Mol Cell Endocrinol. 2017;459:84–9.PubMedCrossRef Cicatiello AG, Ambrosio R, Dentice M. Thyroid hormone promotes differentiation of colon cancer stem cells. Mol Cell Endocrinol. 2017;459:84–9.PubMedCrossRef
38.
Zurück zum Zitat Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol Int. 2006;56(9):485–9.PubMedCrossRef Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K. Cancer stem cell hypothesis in thyroid cancer. Pathol Int. 2006;56(9):485–9.PubMedCrossRef
39.
Zurück zum Zitat Burstein DE, Nagi C, Wang BY, Unger P. 'Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol. 2004;35(4):465–73.PubMedCrossRef Burstein DE, Nagi C, Wang BY, Unger P. 'Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol. 2004;35(4):465–73.PubMedCrossRef
40.
Zurück zum Zitat Takano T, Amino N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid. 2005;15(5):432–8.PubMedCrossRef Takano T, Amino N. Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid. 2005;15(5):432–8.PubMedCrossRef
41.
Zurück zum Zitat Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol. 2007;17(3):233–40.PubMedCrossRef Takano T. Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol. 2007;17(3):233–40.PubMedCrossRef
43.
Zurück zum Zitat Benedict M, Costa J. Metastatic papillary thyroid carcinoma with multifocal synchronous transformation to anaplastic thyroid carcinoma. Case Rep Pathol. 2016;2016:4863405.PubMedPubMedCentral Benedict M, Costa J. Metastatic papillary thyroid carcinoma with multifocal synchronous transformation to anaplastic thyroid carcinoma. Case Rep Pathol. 2016;2016:4863405.PubMedPubMedCentral
45.
Zurück zum Zitat Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007;148(4):1797–803.PubMedCrossRef Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 2007;148(4):1797–803.PubMedCrossRef
46.
Zurück zum Zitat Nagayama Y, Shimamura M, Mitsutake N. Cancer stem cells in the thyroid. Front Endocrinol (Lausanne). 2016;7:20.CrossRef Nagayama Y, Shimamura M, Mitsutake N. Cancer stem cells in the thyroid. Front Endocrinol (Lausanne). 2016;7:20.CrossRef
47.
Zurück zum Zitat Mahkamova K, Latar N, Aspinall S, Meeson A. Hypoxia increases thyroid Cancer stem cell-enriched side population. World J Surg. 2018;42(2):350–7.PubMedCrossRef Mahkamova K, Latar N, Aspinall S, Meeson A. Hypoxia increases thyroid Cancer stem cell-enriched side population. World J Surg. 2018;42(2):350–7.PubMedCrossRef
48.
Zurück zum Zitat Yeung BH, Law AY, Wong CK. Evolution and roles of stanniocalcin. Mol Cell Endocrinol. 2012;349(2):272–80.PubMedCrossRef Yeung BH, Law AY, Wong CK. Evolution and roles of stanniocalcin. Mol Cell Endocrinol. 2012;349(2):272–80.PubMedCrossRef
49.
Zurück zum Zitat Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, et al. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer Res. 2014;33:26.PubMedPubMedCentralCrossRef Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, et al. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer Res. 2014;33:26.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Hayase S, Sasaki Y, Matsubara T, Seo D, Miyakoshi M, Murata T, et al. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells. Thyroid. 2015;25(4):425–36.PubMedPubMedCentralCrossRef Hayase S, Sasaki Y, Matsubara T, Seo D, Miyakoshi M, Murata T, et al. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells. Thyroid. 2015;25(4):425–36.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Saito Y, Onishi N, Takami H, Seishima R, Inoue H, Hirata Y, et al. Development of a functional thyroid model based on an organoid culture system. Biochem Biophys Res Commun. 2018;497(2):783–9.PubMedCrossRef Saito Y, Onishi N, Takami H, Seishima R, Inoue H, Hirata Y, et al. Development of a functional thyroid model based on an organoid culture system. Biochem Biophys Res Commun. 2018;497(2):783–9.PubMedCrossRef
52.
Zurück zum Zitat Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet. 2003;63(6):445–55.PubMedCrossRef Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet. 2003;63(6):445–55.PubMedCrossRef
53.
Zurück zum Zitat Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid. 2009;19(12):1303–15.PubMedCrossRef Klonisch T, Hoang-Vu C, Hombach-Klonisch S. Thyroid stem cells and cancer. Thyroid. 2009;19(12):1303–15.PubMedCrossRef
54.
Zurück zum Zitat Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to graves disease. J Clin Invest. 2005;115(8):1972–83.PubMedPubMedCentralCrossRef Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-associated diseases: from adenomata to graves disease. J Clin Invest. 2005;115(8):1972–83.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Zheng X, Cui D, Xu S, Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 2010;37(2):307–15.PubMed Zheng X, Cui D, Xu S, Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 2010;37(2):307–15.PubMed
56.
Zurück zum Zitat Friedman S, Lu M, Schultz A, Thomas D, Lin RY. 'CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One. 2009;4(4):e5395.PubMedPubMedCentralCrossRef Friedman S, Lu M, Schultz A, Thomas D, Lin RY. 'CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One. 2009;4(4):e5395.PubMedPubMedCentralCrossRef
57.
Zurück zum Zitat Mirshahidi S, Simental A, Lee SC, De Andrade Filho PA, Peterson NR, Cao W, et al. Subpopulations of cancer stem cells found in papillary thyroid carcinoma. Exp Cell Res. 2018;362(2):515–24.PubMedCrossRef Mirshahidi S, Simental A, Lee SC, De Andrade Filho PA, Peterson NR, Cao W, et al. Subpopulations of cancer stem cells found in papillary thyroid carcinoma. Exp Cell Res. 2018;362(2):515–24.PubMedCrossRef
58.
Zurück zum Zitat Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 2013;229(3):355–78.PubMedCrossRef Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, Corbeil D, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 2013;229(3):355–78.PubMedCrossRef
59.
Zurück zum Zitat Canettieri G, Franchi A, Sibilla R, Guzmán E, Centanni M. Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line. J Mol Endocrinol. 2004;33(1):51–8.PubMedCrossRef Canettieri G, Franchi A, Sibilla R, Guzmán E, Centanni M. Functional characterisation of the CRE/TATA box unit of type 2 deiodinase gene promoter in a human choriocarcinoma cell line. J Mol Endocrinol. 2004;33(1):51–8.PubMedCrossRef
60.
Zurück zum Zitat Ambrosio R, De Stefano MA, Di Girolamo D, Salvatore D. Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells. Mol Cell Endocrinol. 2017;459:79–83.PubMedCrossRef Ambrosio R, De Stefano MA, Di Girolamo D, Salvatore D. Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells. Mol Cell Endocrinol. 2017;459:79–83.PubMedCrossRef
61.
Zurück zum Zitat Visser TJ. Thyroid hormone transport across the placenta. Ann Endocrinol (Paris). 2016;77(6):680–3.CrossRef Visser TJ. Thyroid hormone transport across the placenta. Ann Endocrinol (Paris). 2016;77(6):680–3.CrossRef
62.
Zurück zum Zitat Casula S, Bianco AC. Thyroid hormone deiodinases and cancer. Front Endocrinol (Lausanne). 2012;3:74.CrossRef Casula S, Bianco AC. Thyroid hormone deiodinases and cancer. Front Endocrinol (Lausanne). 2012;3:74.CrossRef
63.
Zurück zum Zitat Shimamura M, Yamamoto K, Kurashige T, Nagayama Y. Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines. Exp Cell Res. 2018;370(2):699–707.PubMedCrossRef Shimamura M, Yamamoto K, Kurashige T, Nagayama Y. Intracellular redox status controls spherogenicity, an in vitro cancer stem cell marker, in thyroid cancer cell lines. Exp Cell Res. 2018;370(2):699–707.PubMedCrossRef
64.
Zurück zum Zitat Zhao W, Chen S, Hou X, Chen G, Zhao Y. CHK2 promotes Anoikis and is associated with the progression of papillary thyroid Cancer. Cell Physiol Biochem. 2018;45(4):1590–602.PubMedCrossRef Zhao W, Chen S, Hou X, Chen G, Zhao Y. CHK2 promotes Anoikis and is associated with the progression of papillary thyroid Cancer. Cell Physiol Biochem. 2018;45(4):1590–602.PubMedCrossRef
Metadaten
Titel
Functions of stem cells of thyroid glands in health and disease
verfasst von
Ebtesam A. Al-Suhaimi
Khulood Al-Khater
Publikationsdatum
25.04.2019
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2019
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-019-09496-x

Weitere Artikel der Ausgabe 2/2019

Reviews in Endocrine and Metabolic Disorders 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.